A Clinical Pharmacokinetics Study of NI-071.
Phase of Trial: Phase I
Latest Information Update: 09 Nov 2016
Price : $35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Nichi-Iko Pharmaceutical
- 01 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Sep 2013 New trial record